Lite Version|Standard version

To gain access to this content please
Log in via your home Institution.
Log in with your member or subscriber username and password.
Download

The transformation of the piroxicam monohydrate to form I or form II could be achieved precisely by adjusting the particle size itself in a 99% acetone-1% H2O solvent at 31 °C. Mechanistic studies have demonstrated that the particle size could affect both the maximum concentration of piroxicam and the heterogeneous nucleation of form II during the solution-mediated phase transformation (SMPT) process, finally determining the polymorph outcome.

Graphical abstract: Size-dependent solution-mediated phase transformation of piroxicam monohydrate particles

Page: ^ Top